DNMT1 and cancer: In light of the recent findings that melatonin combined with conventional anti-cancer therapy could limit the adverse effect of chemotherapy and increase its therapeutic efficacy, including reducing drug resistance [159,160,161,162,166,167], its simultaneous use with DNMT inhibitors or other epigenetic drugs may be a more efficient approach to avoid the limitations of epigenetic drugs.